COVID-19

There are myriad opportunities to use digital tech to improve lab efficiency.

Mighty mRNA molecules have won the COVID-19 vaccine race, but there is room for improvement.

Keeping tabs on the efficacy of COVID-19 vaccines.

How do we vaccinate billions of people? “Nobody wins the race until everyone wins.”

Billions of vaccine doses equate to a need for billions of primary packaging units – and glass vials are still top dog.

What factors influence the public’s perception of the pharmaceutical industry?

We get the rundown on mRNA vaccine manufacturing. How were the vaccines developed so quickly?

What are the challenges of ensuring COVID-19 vaccine access worldwide?

COVID-19 has put the spotlight on the weaknesses of today’s highly dispersed, globalized pharma industry. Is onshoring the answer?

Let’s not ride roughshod over patient autonomy when it comes to national vaccination campaigns.